SELUMETINIB, SELUMETINIB, Selumetinib, Selumetinib
SPRINKLE D1346C00004
Phase 2 small_molecule active
Quick answer
SELUMETINIB, SELUMETINIB, Selumetinib, Selumetinib for Neurofibromatosis Type 1 (NF1) Related Plexiform Neurofibromas (PN) is a Phase 2 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Neurofibromatosis Type 1 (NF1) Related Plexiform Neurofibromas (PN)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active